Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 7, 2015
(Thomson Reuters ONE) -
GAITHERSBURG, Md., April 30, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc.,
(Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery,
development and commercialization of recombinant nanoparticle vaccines and
adjuvants, today announced it will report its first quarter 2015 financial and
operating results after the close of U.S. financial markets on Thursday, May
7, 2015.
In addition, management will host a conference call to discuss the quarterly
results and provide an update on corporate activities.
Conference call details are as follows:
Date: May 7, 2015
Time: 4:30 pm US Eastern Time
Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International)
Via web: www.novavax.com, "Investor Info"/"Events"
Conference call replay:
Dates: Starting at 7:30 pm ET on May 7, 2015 until midnight May
14, 2015
Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International)
Passcode: 35660022
Via web: www.novavax.com, "Investor Info"/"Events"
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to
delivering novel products to prevent a broad range of infectious diseases. Its
recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the
foundation for ground-breaking innovation that improves global health through
safe and effective vaccines. Additional information about Novavax is available
on the company's website, www.novavax.com.
CONTACT: Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir(at)novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull(at)russopartnersllc.com
todd.davenport(at)russopartnersllc.com
212-845-4271
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Novavax, Inc. via GlobeNewswire
[HUG#1917366]
Unternehmensinformation / Kurzprofil:
Datum: 30.04.2015 - 22:06 Uhr
Sprache: Deutsch
News-ID 390115
Anzahl Zeichen: 2858
contact information:
Town:
Maryland
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 170 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 7, 2015"
steht unter der journalistisch-redaktionellen Verantwortung von
Novavax, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
